Predicting and monitoring response to chemotherapy by 1,3‐bis(2‐chloroethyl)‐1‐nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI

To examine the effects of the alkylating anticancer drug 1,3‐bis(2‐chloroethyl)‐1‐nitrosourea (BCNU) on 23Na MRI and the water apparent diffusion coefficient (ADC) in subcutaneously‐ (sc‐) implanted 9L glioma in rats.

[1]  R. Langer,et al.  Cell‐killing potential of a water‐soluble radical initiator , 2001, International journal of cancer.

[2]  R. Tamargo,et al.  In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology. , 1988, Cancer research.

[3]  Bradford A Moffat,et al.  Evaluation of cancer therapy using diffusion magnetic resonance imaging. , 2003, Molecular cancer therapeutics.

[4]  Britton Chance,et al.  Cyclophosphamide treatment modifies tumor oxygenation and glycolytic rates of RIF-1 tumors: 13C magnetic resonance spectroscopy, Eppendorf electrode, and redox scanning. , 2003, Cancer research.

[5]  Franklyn A. Howe,et al.  Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo , 1999 .

[6]  T L Chenevert,et al.  Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Harish Poptani,et al.  Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma. , 2001, Cancer research.

[8]  R. Gillies,et al.  Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. , 1999, Neoplasia.

[9]  Hong Zhang,et al.  Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors. , 2005, Neoplasia.

[10]  J. Pipe,et al.  Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. , 1996, British Journal of Cancer.

[11]  Bradford A Moffat,et al.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Chenevert,et al.  Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S E Maier,et al.  Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. , 2001, Cancer research.

[14]  Jan Wolber,et al.  Diffusion MRI for prediction of response of rectal cancer to chemoradiation , 2002, The Lancet.

[15]  J. M. Taylor,et al.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.

[16]  J. Petruccelli,et al.  Comparison of the return‐to‐the‐origin probability and the apparent diffusion coefficient of water as indicators of necrosis in RIF‐1 tumors , 2003, Magnetic resonance in medicine.

[17]  Alnawaz Rehemtulla,et al.  Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma , 2005, Magnetic resonance in medicine.

[18]  T. Duong,et al.  Extracellular apparent diffusion in rat brain , 2001, Magnetic resonance in medicine.

[19]  N. Bansal,et al.  Three‐dimensional triple quantum‐filtered 23na imaging of rabbit kidney with weighted signal averaging , 1995, Journal of magnetic resonance imaging : JMRI.

[20]  S Vinitski,et al.  Effect of the sampling rate on magnetic resonance imaging , 1987, Magnetic resonance in medicine.

[21]  N. van Bruggen,et al.  Quantification of tumor tissue populations by multispectral analysis , 2004, Magnetic resonance in medicine.

[22]  Bradford A Moffat,et al.  Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker , 2004, Clinical Cancer Research.

[23]  Detecting early response to cyclophosphamide treatment of RIF‐1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging , 2003, NMR in biomedicine.

[24]  Steen Rg,et al.  Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. , 1989 .

[25]  R G Steen,et al.  Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. , 1989, Cancer research.